The Role of Compassionate Use & Expanded Access Programs in Epidemics & Pandemics: A Look at COVID-19 & Ebola

• Examine how Compassionate Use and Expanded Access Programs operate in fast-moving outbreaks, using Ebola and COVID-19 to illustrate the clinical, regulatory, and ethical landscape
• Compare two approaches our team deployed in each outbreak, explaining when and why they were chosen, how they were implemented, and their impact on patient access

Speakers:

Maggie Loughran

Manager, Global Medical Operations, Global Clinical Development

Regeneron Pharmaceuticals

David Stein

Senior Director, Global Medical Operations, Global Clinical Development

Regeneron Pharmaceuticals